Frequency of hepatitis C viral RNA in anti-hepatitis C virus non-reactive blood donors with normal alanine aminotransferase

Journal of the College of Physicians and Surgeons Pakistan

Volumn 20, Issue 10, 2010, Pages 662-666

  Ali, Nadir ^a   Moinuddin, ^b   Ahmed, Syed Azhar ^b   Chotani, Rashid A ^c   Fisher Hoch, Susan P ^d  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

^b BAQAI MEDICAL UNIVERSITY   (Pakistan)

^c Uniformed Services University of the Health Sciences   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Anti HCV negative; Blood donors; HCV RNA; Hepatitis C virus

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; RHESUS C ANTIBODY; VIRUS RNA; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; OBSERVATIONAL STUDY; REAL TIME POLYMERASE CHAIN REACTION; SCREENING TEST; UNSTRUCTURED INTERVIEW; BLOOD; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED;

ADULT; ALANINE TRANSAMINASE; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; YOUNG ADULT;

EID: 78049427261     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Pardo M, López-Alcorocho JM, Castillo I, Rodríguez- Iñigo E, Perez-Mota A, Carreño V. Effect of antiviral therapy for occult HCV infection. Aliment Pharmacol Ther 2006; 23:1153-9.
2. Colin C, Lanoir D, Touzet S, Meyaud-Kraemer L, Bailly F. Hepatitis C. Sensitivity and specificity of third-generation hepatitis C virus anti-body detection assays: an analysis of the literature. J Viral Hepat 2001; 8:87-95.
3. Pawlotsky JM, Lonjon I, Hezode C, Raynard B, Darthuy F, Remire J, et al. What strategy should be used for diagnosis of Hepatitis C virus infection in clinical laboratories? Hepatology 1998; 27:1700-2.
4. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002; 36:S65-73.
5. Schröter M, Schäfer P, Zöllner B, Polywka S, Laufs R, Feucht HH. Strategies for reliable diagnosis of hepatitis C infection: the need for serological confirmatory assay. J Med Virol 2001; 64:320-4.
6. Netski DM, Mosbruger T, Depla E, Maertens G, Ray SC, Hamilton RG, et al. Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis 2005; 41:667-75. Epub 2005 Jul 22.
7. Schüttler CG, Thomas C, Discher T, Friese G, Lohmeyer J, Schuster R, et al. Variable ratio of hepatitis C virus RNA to viral core antigen in patient sera. J Clin Microbiol 2004; 42:1977-81.
8. Schüttler CG, Thomas C, Discher T, Friese G, Lohmeyer J, Schuster R, et al. Procleix Ultrio transcription-mediated amplification vs. serological blood screening in South-Western Greece. Transfus Med 2008; 18:104-11.
9. Kaur P, Basu S. Transfusion-transmitted infections: existing and emerging pathogens. J Postgrad Med 2005; 51:146-51.
10. Eiras A, Sauleda S, Planelles D, Sedeño M, Ibarra A, Vesga MA, et al. HCV screening in blood donations using RT-PCR in mini-pool: the experience in Spain after routine use for 2 years. Transfusion 2003; 43:713-20.
11. Martinot-Peignoux M, Boyer N, Cazals-Hatem D, Pham BN, Gervais A, Le Breton V, et al. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA. Hepatology 2001; 34:1000-5.
12. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007; 47:316-25.
13. Idrees M, Lal A, Naseem M, Khalid M. High prevalence of hepatitis C virus infection in the largest province of Pakistan. J Dig Dis 2008; 9:95-103.
14. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, et al. Impact of individual-donation nucleic-acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Transfusion 2009; 49:1115-25. Epub 2009 Feb 27.
15. Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006; 19:165-256.
16. Ahmad N, Asgher M, Shafique M, Qureshi JA. An evidence of high prevalence of hepatitis C virus in Faisalabad, Pakistan. Saudi Med J 2007; 28:390-5. (Pubitemid 46605059)
17. Abdul Mujeeb S, Nanan D, Sabir S, Altaf A, Kadir M. Hepatitis B and C infection in first-time blood donors in Karachi: a possible subgroup. East Mediterr Health J 2006; 12:735-41.
18. Ishaq S, Ali SS, Karim N, Umrani NI, Hassan N. Frequency of hepatitis B and C virus among the healthy volunteer blood donors at Taulka Hospital Sujjawal, District Thatta, Sindh. Ann Abbasi Shaheed Hosp Karachi Med Dent Coll 2007; 12:97-101.
19. Mujeeb SA. Pearce MS. Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan. BMC Infect Dis 2008; 8:43.
20. O'Brien SF, Fan W, Xi G, Yi QL, Goldman M. Evaluation of the confidential unit exclusion form: the Canadian Blood Services experience. Vox Sang 2009; 98:138-44. Epub 2009 Sept 14.
21. Roth WK, Weber M, Buhr S, Drosten C, Weichert W, Sireis W, et al. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion 2002; 42:862-8. Comment in: Transfusion 2005; 45:1040-2.
22. Jarvis LM, Dow BC, Cleland A, Davidson F, Lycett C, Morris K, et al. Detection of HCV and HIV-1 anti-body negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing. Vox Sang 2005; 89:128-34. Comment in: Vox Sang 2006; 90:204.
23. Allain JP, Stramer SL, Carneiro-Proietti AB, Martins ML, Lopes da Silva SN, Ribeiro M, et al. Transfusion-transmitted infectious diseases. Biologicals 2009; 37:71-7. Epub 2009 Feb 20.
24. Dodd R, Kurt Roth W, Ashford P, Dax EM, Vyas G. Transfusion medicine and safety. Biologicals 2009; 37:62-70. Epub 2009 Feb 20.
25. Seme K, Mocilnik T, Fujs K, Babic DZ, Todorovic A, Fres-Stefan T, et al. Twenty-four mini-pool HCV RNA screening outside a blood transfusion setting: results of a 2-year prospective study. J Virol Methods 2007; 140:218-21.
26. Bamaga MS, Bokhari FF, Aboud AM, Al-Malki M, Alenzi FQ. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations. Saudi Med J 2006; 27:781-7.
27. Palomäki P, Wessberg S, Tuomi K, Laitinen H. Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS Ampli Screen method. Transfusion 2005; 45:1518-22.
28. Forcic D, Zgorelec R, Kosutic-Gulija T, Ivancic J, Baricevic M, Lupret l, et al. Screening of serologically negative plasma pools for hepatitis C virus by nucleic acid amplification testing in Croatia, 2001-2003. Transfus Apher Sci 2005; 33:175-9.
29. Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, et al. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations. Transfusion 2005; 45:1258-66.